Norbrook Laboratories Ltd has launched Mycinor tablets (clindamycin), an antibiotic for treating soft tissue infections in dogs.
Rebekah Dudek, Norbrook Veterinary Advisor said: "Clindamycin is one of the leading prescription medicines used to treat soft tissue infections and offers very effective treatment particularly for dental and oral infections.
"Mycinor can be used to treat infected mouth cavities and oral infections and to provide antimicrobial cover prior to dental procedures such as tooth removal, scale & polish etc. Beyond dental expertise, Mycinor can also be used to treat soft tissue infections, skin infections in the form of superficial pyoderma and osteomyelitis bone infections. Mycinor is a fast acting antibiotic, rapidly absorbed into the body with effective levels within 30 minutes of administration."
Mycinor is available as 25mg, 75mg and 150mg in packs of 100tablets, and as a 300mg tablet in a pack of 150 tablets. Rebekah added: "Mycinor is a very effective and safe antibiotic and is ideal for long and short term treatments. It can be dosed once daily or at twice daily intervals if preferred."
For more information, visit www.norbrook.com
The RSPCA is asking veterinary surgeons to take part in a new survey which aims to build a true picture of the scale of the problem of illegally imported puppies being brought into the UK.
Amongst other things, the survey asks what you consider to be the greatest concerns regarding the poor breeding, dealing and illegal import of puppies and what you think can be done to tackle these and the associated problems.
You can take part in the survey here: www.surveymonkey.com/s/QQNBVFV
James Yeates, Chief Veterinary Officer, said: "RSPCA intelligence suggests that there is a growing illegal trade in puppies from other EU countries and is causing serious health and welfare problems. In many cases puppies are dying or becoming seriously ill. Risk factors appear to include being taken from their mothers too early, not being vaccinated and having to endure long journeys in poor conditions.
"However, it's very difficult to get a full view on the scale of the problem as many cases never get reported to the RSPCA. Vets are likely to be the first port of call when a puppy bought by an unsuspecting buyer becomes sick and may be faced with many of these cases - if sadly not all.
"We're interested in hearing from vets to get their evidence from practice and to hear their ideas about how we can tackle the lucrative illegal trade in puppies."
The weekly sessions will offer practical guidance for veterinary surgeons and nurses about how they can manage chronic cases in line with guidelines issued by the Royal College of Veterinary Surgeons, the British Veterinary Association and the government.
Dechra’s Veterinary Technical Advisor Emily Casey BVM&S MRCVS will present the first webinar tackling Addison’s disease on Thursday April 2 from 1pm to 2pm and again from 7pm to 8pm. It will be available to watch again or download via the Dechra Academy.
It will include advice on how to stabilise patients and administer Zycortal while respecting government guidelines, including prioritisation of blood testing, use of telemedicine and provision of additional owner support. Each webinar represents one hour of CPD.
Dechra’s Technical Services Manager Jamie Walker said: “Since the outbreak of coronavirus began, we have received a large number of calls from practices wanting advice and guidance on how they should be managing chronic cases at this time.
"Our case management webinars will offer practical advice on a number of common small animal issues and aim to provide reassurance and support to veterinary professionals at this challenging time."
Further webinars will be held each Wednesday in April.
To register for the free webinars visit www.dechra.co.uk/events.
Kate said: "In recent days we have watched the unfolding events in Ukraine in horror, shock and with tremendous sadness.
"We are determined to offer as much help and support as we can to our Ukrainian veterinary colleagues fleeing this crisis and seeking refuge in the UK.
To that end, the College offers a financial support scheme for refugees which is immediately available for Ukrainian veterinary surgeons with refugee status.
The scheme enables refugee vets to take the RCVS Statutory Examination for free, offers financial support to attend exams, free access to the RCVS library and free membership of BSAVA, BVA, BEVA, BCVA and VMG.
In addition, whilst Russian-based business interests comprise less than 0.1% of the College's investment portfolio, it has instructed its fund managers to get rid of all Russian investments at the very earliest opportunity.
Meanwhile, veterinary dentist Bob Partridge has donated a day's takings from his Harrogate-based, Specialist-led small animal dental referral practice, VetDentist, to the British Red Cross Ukraine.
He said: "I got home late and exhausted, turned on the news, and knew that my “tough day” was as nothing compared to the troubles, the fear and the pain experienced by the people of Ukraine."
Other members of Bob's team followed suit, as did the team at Training-Progress, and they hope others will do the same.
Bob said: "Please put your money where your mouth (or keyboard) is!"
https://donate.redcross.org.uk/appeal/ukraine-crisis-appeal
Photo: CC BY-SA 2.0 Aleksej Leonov
Jason (pictured right with Paul), said: "Let me tell you, that was hard! Nine days and 900km of mountain bike riding, with 250km technical single track and only about 10 km tar, but we did it! We are so proud to be able to contribute to a future for rhinos!"
The veterinary velocipedists were raising money for The Chipembere Foundation, which specialises in sourcing, testing and funding technology for monitoring rhinos. They fund K9 handlers and their tracking and apprehension dogs, as well as funding and providing anti-poaching teams with vital equipment needed to translocate rhinos across Southern Africa.
It costs about £38000 to translocate a rhino from South Africa to neighbouring Botswana where there is less poaching (for now). Satellite tracking leg collars cost £1500 with an annual service and VHF collars and transmitters costing around £220. Dog and dog handler training is in the region of around £5000 per dog and there are additional costs for kennels, transport vehicles and day to day items like bowls, brushes, leads etc.
If you want to support Jason and Paul in their efforts to make a positive difference to the plight of the fast-dwindling numbers of rhino, visit www.justgiving.com/teams/rhinocycle.
They say this approach could lead to a reduction in the number of vaccines that need to be administered to each bird.
Vaccines that target multiple diseases are in high demand due to the many viruses that can circulate simultaneously in flocks. Protecting against the most dangerous diseases with one vaccine could reduce overall vaccination costs for poultry producers and decrease the number of times that birds need to be handled.
The researchers demonstrated that a gene editing system called CRISPR/cas9 can be used to insert a gene of the IBD virus into the currently used Marek’s disease vaccine virus. The added genetic material protects poultry against IBD in addition to the protection already offered by the Marek’s disease vaccine, meaning that bird owners would only need to use one vaccine instead of two.
Other vaccines generated by conventional methods can achieve a similar result, but by using the CRISPR/cas9 system the Pirbright researchers say they have been able to insert the IBD gene far more quickly, easily and accurately than the methods that have been used before. This will significantly reduce the time needed to generate new vaccines.
Professor Venugopal Nair, joint leader of the research at Pirbright said: "The method we have created with CRISPR/cas9 really increases the scope of how we edit the Marek’s disease vaccine to include other virus components. Now we have shown that the gene-edited vaccine protects against both Marek’s disease and IBD, we are looking at inserting more genes from other viruses."
The team intend to generate a vaccine that will be able to protect against multiple avian diseases and will next target two high consequence poultry viruses - avian influenza virus and the Newcastle disease virus. The flexibility of the new method also means that as the viruses evolve, the vaccine virus can be easily edited to include new genes which protect against emerging strains.
The Pirbright Institute says there has been huge commercial interest in using this technology to develop novel vaccines, so it intends to partner vaccine manufacturing companies to bring CRISPR/cas9 edited vaccines to market.
This scientific paper can be found in the Vaccine journal and was funded by the Biotechnology and Biological Sciences Research Council (BBSRC); grant numbers BB/P016472/1 BB/L014262/1.
Photo: Cells infected with the Marek's disease vaccine virus, HVT, (green) expressing the inserted infectious bursal disease virus gene, VP2 (red). Cell nuclei are shown in blue. © Dr Na Tang, The Pirbright Institute 2018.
Prior to becoming COO, Tim was Managing Director of three referral hospitals owned by Linnaeus – Davies Veterinary Specialists, London Veterinary Specialists and Southfields Veterinary Specialists – and a number of its primary care sites.
Prior to joining Linnaeus, Tim worked in Iceland, where he was a vet for the Icelandic Government.
On his return from Iceland in 2016, he joined Village Vet and then progressed into a range of regional management and practice leadership positions across the industry.
Tim said: "I am proud to be part of our wonderful, unique industry that, although currently facing a number of challenges, continues to make such a difference to the lives of our patients and their owners every day.
“In my first vet role in mixed practice, I was fortunate to receive brilliant support, guidance and encouragement from my team.
"Since then, I have always wanted to do the same for my colleagues, particularly those who are just starting their careers.
“I have used my experience within the veterinary profession to support some fantastic teams at Linnaeus.
"Becoming COO is an honour and opportunity that will enable me to help even more people across the business.”
The training facility is over 800m2 and houses 18 working stations, three lecture rooms, the latest training technology, a leisure area and library with outdoor space and parking.
Heber Alves, CEO of the Improve International Group said: “It has been a goal of ours for a long time to open a new, top-of-the-range training facility for veterinary professionals in Germany.
"We are delighted to see this dream come true and we are very excited to now have the opportunity to work more closely with vets and veterinary technicians and help them grow their skillsets.”
www.improveinternational.com.
Under the RCVS Code of Professional Conduct veterinary surgeons are expected to demonstrate that they are keeping their skills and knowledge up-to-date by engaging in at least 105 hours of CPD over a rolling three-year period.
As part of the auditing process the 1,071 vets will be asked to share their CPD records for 2014 to 2016, either by allowing the College to access their online Professional Development Record or by sending the College a copy of their CPD record card.
The audit will focus on six groups:
The College says that if any of the veterinary surgeons who have been audited are found to be non-compliant they will be asked to explain why and send a plan stating how they will make up the hours in order to become compliant.
The deadline for sharing records is Tuesday 31 October 2017.
As part of the auditing process the College is reminding veterinary surgeons that CPD encompasses a wide range of recorded activities, which can be clinical or non-clinical, including private reading/study, webinars, mentoring, clinical audit and discussion groups as well as attending seminars and workshops.
Don't forget that reading content and participating in forum discussions on VetSurgeon.org can count towards your annual requirement, using the 'Claim CPD' feature at the top of each page.
Those with any questions about the auditing process or what constitutes CPD can contact Jenny Soreskog-Turp, RCVS Education Officer, on cpd@rcvs.org.uk.
Researchers say that whilst widely discussed, many in the profession may not be aware that prevalence of the disease has been steadily increasing across all regions of the UK.
Since November 2012, 177 cases have been reported, with more than 90% between November and May. However, the cause of CRGV, which often presents as ulcerations to the dog’s skin and can lead to acute kidney injury (AKI) and potentially death, remains unknown.
Practices are being now asked to report suspect cases in a bid to gain vital insight into the disease and what may be causing it.
David Walker BVetMed (Hons) DipACVIM DipECVIM-CA from Anderson Moores (pictured right) is helping lead the research: "CRGV is a disease that impacts lots of breeds across the UK. Reports show there is seasonality to the disease and therefore an environmental cause is a possible component in its development.
"This research is part of the puzzle and will hopefully help to guide further work on this disease. By collecting more information on confirmed cases, such as walking habits and diet, we hope to build more understanding in order to better protect pets and inform treatment decisions."
To gather this information, Anderson Moores is asking practices to share a 10-minute online survey with the owners of dogs in which CRGV has been confirmed, as well as some control dogs following criteria provided with the survey link.
David said: "Many pet owners are aware of this disease and are concerned for their pets; if they are asked to help they are usually happy to do so. By offering a direct link to the survey, very little of the veterinarian’s time is needed to collate the information."
If you have a suspected case of CRGV, contact Anderson Moores on 01962 767920 or email medicine@andersonmoores.com
If the pet does not survive, then histopathologic assessment of tissue will be performed free of charge to confirm the diagnosis.
In confirmed cases the veterinary surgeon will be sent a link to a 10-minute survey to be completed by the owner.
Along with encouraging the owner of the confirmed case to take part, four unaffected control cases from the same clinic, on the same day, will also need to be recruited.
When a set of five qualifying surveys (one confirmed case and 4 control cases) are provided, practices can claim an Amazon Echo Dot, provided by Bayer, as a thank you for helping with the research.
The four organisations have written a template letter which anyone can send to any company they see using brachycephalic breeds, such as the Persian, or Scottish Folds, in its marketing materials.
The letter urges companies that use images of cats to work collaboratively with veterinary professionals and pledge to avoid using such breeds in the future.
Dr Nathalie Dowgray, Head of ISFM, said: “Seeing a cute cat in an advertisement can often be a trigger for people to seek out acquiring a cat of that breed without understanding the welfare concerns associated with some pedigree breeds.
"A rise in demand can lead to an increase in breeding practices that result in severe conformational issues and poorer welfare in these breeds.
"We encourage people to download this letter to use when they see breeds of concern being used in advertising, as health is always more important than looks.”
https://icatcare.org/app/uploads/2023/09/ISFM_FECAVA_FVE_UEVPAdvert_Letter.pdf.
Intervet/Schering-Plough Animal Health has announced the launch of PORCILIS AR-T DF, an inactivated vaccine against progressive atrophic rhinitis in piglets with a new adjuvant which the company says is associated with fewer injection site reactions.
PORCILIS AR-T DF uses DILUVAC FORTE (DF), an aqueous vitamin E-based adjuvant and will replace PORCILIS AR-T, a similar vaccine containing an oil-based adjuvant. The newly formulated vaccine is approved to reduce the clinical signs of progressive atrophic rhinitis in their offspring. Progressive atrophic rhinitis is caused by a toxin from the bacteria Pasteurella multocida affecting bone-forming cells in the snout of the young piglet.
Marc Dickie, Senior Director, Global Swine Business Unit at Intervet/Schering-Plough Animal Health said: "The innovative PORCILIS AR-T DF vaccine combines the proven efficacy of the current PORCILIS AR-T with an improved safety profile and convenience for the veterinarian that is offered by the aqueous DILUVAC FORTE adjuvant. The new vaccine also demonstrates the commitment of our company to continuously improve our vaccines, thereby offering value-added benefits to our customers."
There will now be significant changes to the RCVS Council, as follows:
A gradual reduction in the number of elected members of RCVS Council from the current 24 to 13 by the year 2021.
A change of composition to include six lay members and two veterinary nurse members. Furthermore, the number of Council members appointed by each university whose veterinary degree is recognised by the RCVS will be reduced from two to one and Privy Council will no longer be required to appoint members. From 1 July 2020 university membership will undergo further changes as, from then on, veterinary schools will collectively appoint three members in total to serve on Council.
Members of Council will no longer be able to serve more than three consecutive four-year terms of office and, after serving three consecutive terms, they will not be eligible to re-stand as a candidate for two years.
Members of Council may be removed from office if they fail to satisfy any conditions about fitness to be a member, as determined by their peers on Council. If removed from office they will not be eligible to re-stand as a candidate for two years.
Introducing the LRO before the House of Lords last Tuesday, Lord Gardiner of Kimble said: "The proposed changes… reduce the size of Council and revise the balance of membership between vets and non-vets, including veterinary nurses and lay persons. They will bring the RCVS in-line with many other modern-day regulatory bodies and allow for greater efficiency, transparency and accountability to both members and the general public. For all the reasons I have outlined today, I commend the use of Legislative Reform Order to make changes that will benefit the veterinary profession."
The full text of the Legislative Reform Order can be found on www.legislation.gov.uk and the full transcript of the debate in the House of Lords can be found in Hansard Online (https://hansard.parliament.uk).
Professor Stephen May, RCVS President, said: "We have been looking at reform of Council as an issue of some urgency since 2013, in recognition of the fact that, with the formula-driven growth of Council, it was becoming unwieldy, which has an impact on the cost of each meeting and the frequency with which it could reasonably meet.
"This reform has been long in gestation and so we are glad that this has now been approved and that we can look forward to a more modern, agile and efficient governance structure, aimed as always at benefitting the professions, animal owners and animal health and welfare."
One immediate impact of the LRO relates to the results of this year’s RCVS Council election as the Ministerial sign-off now confirms that only the first three candidates (in order of number of votes) will take up their four-year terms at RCVS Day on Friday 13 July 2018. These are Susan Paterson, Mandisa Greene and Neil Smith, all of whom are current members who were re-elected.
The RCVS Veterinary Nurses Council agreed reforms to its own governance last year, including shortening the term of office from four years to three years; introducing a consecutive three-term limit for elected members; and, reducing the size and changing the composition of VN Council to six elected veterinary nurses, two appointed veterinary nurse members, two appointed veterinary surgeon members from RCVS Council, and four appointed lay members.
A new injectable antibiotic with nil-milk-withhold licensed to treat foul-in-the-foot in a single shot has been launched by Pfizer Animal Health.
Naxcel Cattle's active ingredient is ceftiofur in a patented sustained-release formulation. According to the company, one injection provides a full course of antibiotic therapy, giving seven days of therapeutic blood levels against the majority of inter-digital necrobacillosis ('foul-in-the-foot') pathogens.
Pfizer vet Dave Gilbert says the expectation is that Naxcel Cattle will make on-farm therapy easier and help improve treatment compliance and thereby first treatment success rates, compared to treatments which require repeat injections. "Having the full course in a single injection simplifies treatment protocols and eliminates a number of reasons for non-completion of treatment, such as forgetting a second or third dose, or not giving them because of apparent symptomatic recovery from the condition."
The site of injection for Naxcel Cattle is the subcutaneous area at the base of the ear (see Figures 1 & 2). Injection instructions are supplied in the product pack. Dave Gilbert suggests that provided cattle are adequately restrained during administration the injection technique is simple and straightforward. The dose rate is 1ml/30kg body weight and up to 30ml can safely be given into each site.
Figure 1. Subcutaneous administration of Naxcel Cattle at the posterior aspect of the ear where it attaches to the head (base of ear).Figure 2. Injection location for the subcutaneous administration of Naxcel Cattle at the posterior aspect of the ear where it attaches to the head (base of ear).
Currently used by more than 200 practices and 50 universities around the world, the Equinosis Q is a diagnostic tool that can further aid the subjective lameness evaluation on all types of horses and ponies examined in the field or in hospital settings.
Christina Frigast, MRCVS, Eickemeyer Product Development Manager said: "The inertial sensors sample 20x faster than the human eye making the Equinosis Q a valuable tool to the veterinarian in the evaluation of subtle and multiple limb lameness.
"It does not interfere with the routine lameness examination as trot up on straight line, lunging and ridden evaluations can be performed on both hard and soft surfaces.
"Data is wirelessly streamed to a tablet PC and compiled into a reader-friendly report displaying the timing and severity of lameness. The effectiveness of diagnostic blocks can also be assessed with the Equinosis Q, providing the veterinarian with a percentage of improvement. In addition, comparison reports can be used to monitor rehabilitation progress."
Contact Eickemeyer to book a free demo, or for further information, visit: https://www.eickemeyer.co.uk/Diagnostics-and-Education/Anatomy-Models/Lameness-Locator-vet.html?listtype=search&searchparam=lameness
watch?v=MS6UXQSq6q0
The CVS practice aimed to change its prescribing culture by adopting an evidence-based, case-by-case approach and supporting its vets in only using antibiotics where absolutely necessary.
The practice identified the use of antibiotics in the treatment of cat bite abscesses (CBAs) as worthy of investigation.
Cefovecin, a third-generation cephalosporin and critically important antibiotic, is often used in the treatment of CBAs.
The practice first sought guidance from a dermatology specialist with an active research programme involving the study of antimicrobial resistance (AMR).
It then developed a clinical guideline advising that if a cat has a discrete abscess, with no pyrexia (raised temperature) and no cellulitis, antibiotics are not required.
White Lodge then conducted an eight-month clinical audit across its Exmouth Hub, with the aim of measuring the effect of the new guideline.
The practice treated patients with CBA’s with NSAIDS, lancing and flushing (if necessary), and cleaning of the abscess.
Owners were advised to flush the affected area at home once daily.
An antibiotic awareness leaflet was given to clients with an explanation of the reasoning behind not prescribing antibiotics.
Cats presented 5-7 days after treatment for a nurse re-examination.
A consultation template was created for both the vet at initial presentation and another for the nurse’s post treatment check, to gather standardised information.
The measure of successful treatment was whether, on re-examination, the CBA site appeared free from infection and wound healing was evident.
If the wound had not started to heal or if there was infection or pyrexia, the treatment was deemed to have failed and further treatment was provided.
Analysis of the results showed that of the 22 cats included in the audit, 19 (86%) did not need antibiotics to successfully treat the abscess.
There was also a 32.6% reduction in the number of times cefovecin was dispensed in the eight-month period after the audit started, compared with the previous eight months.
Emily Parr, Head Veterinary Surgeon at White Lodge, said: “We think, due to lack of confidence in treatment without antibiotics as well as client pressure or expectation, the profession tends to default to the prescribing of antibiotics.
“However, this clinical audit has given our veterinary colleagues increased confidence in treating CBA’s without antibiotics.
"There has also been an improved client understanding in accepting treatment without antibiotics.
"Clients have also been positive when minimal intervention has been required, particularly as it eliminates the cost of antibiotics.
"This has had a positive impact on the vet-client relationship and trust in our practice.
“Antimicrobial resistance is continuing to threaten the efficacy and treatment of an ever-increasing range of infections.
"So we hope that our CBA clinical audit outcome results will help to set a benchmark and shape clinical guidelines for the wider veterinary profession in this area.”
Sanofi-aventis has signed an agreement under which it will buy Merck & Co Ltd's 50% stake in Merial Limited for $4 billion cash, after which it will own Merial outright.
According to the Wall Street Journal, Merck is selling its stake in Merial to avoid concerns from antitrust regulators that its pending acquisition of Schering-Plough will make it too dominant.
Merck, sanofi-aventis and Schering-Plough have also announced another agreement under which sanofi-aventis will have the option to combine Merck's Intervet/Schering-Plough Animal Health business with Merial to form an animal health joint venture owned equally by Merck and sanofi-aventis.
I thought Merial-Intervet-Schering-Plough was a bit of a mouthful, but sanofi-aventis-Merial-Intervet/Schering-Plough? The receptionist is going to have her work cut out.
The RCVS is holding a session at the London Vet Show on Saturday 23rd October from 8:30am-9:30am to provide guidance and advice concerning the work your nursing team does in practice.
As the RCVS says, the recent Panorama programme "It shouldn't happen at a vets'" was a stark reminder of the importance of ensuring that all practice staff are working within the appropriate legal framework.
The session will answer such questions as:
Because of the early start, the RCVS is providing breakfast from 8:15am, though I wouldn't get your hopes up for eggs benedict and freshly smoked Loch Fyne kippers.
The RCVS says the session will be relevant for all members of the practice team, but that if you can't make the session, they will be on hand to discuss VN legislation on stand M26.
BVA President Harvey Locke used his annual London dinner speech last night to urge the Government to take action on veterinary student fees and the welfare of dogs, and respond to the consultation on dangerous dogs.
Guests at the dinner included The Rt Hon Caroline Spelman MP, Secretary of State for Defra, parliamentarians, veterinary surgeons, and representatives from the agri-food industry, pet industry, welfare charities, research and veterinary education.
Mr Locke began by raising concerns over cuts to animal health and welfare and disease surveillance budgets: "In the Comprehensive Spending Review Defra took one of the biggest hits. The profession remains deeply concerned that cuts in research and development and disease surveillance could have catastrophic consequences. Right now the UK enjoys some of the highest animal health and welfare standards in the world and so it is in all of our interests to ensure the viability of the farming sector amidst massive competition from abroad, where those standards may not always be as high."
On veterinary student fees, Mr Locke outlined the 'double whammy' of a long course and compulsory Extra Mural Studies in the holidays: "Our role as the guardians of animal health and welfare faces an uncertain future following the announcement that the cap on tuition fees will be raised to between 6 and 9 thousand pounds a year. We fear this could have a huge impact on the decisions of A-level students, with fewer and fewer opting for an expensive veterinary science degree.
"Although the plans are not yet finalised we are bracing ourselves for veterinary degrees, which are costly to run, to be priced at the top of the scale, meaning veterinary students of the future will graduate with at least £45,000 of debt in tuition fees alone. Faced with these levels of debt, our concern is that those who do make it to graduation won't opt for the food animal practice and public health roles that attract smaller pay packages. We need to think carefully about how we can secure the future provision of large animal practitioners."
On companion animal issues Mr Locke asked Defra not to defer all decisions on dog welfare to the newly-formed Dog Advisory Council: "While the BVA fully supports the Advisory Council, we would urge the Government not to use it to delay decisions that might improve the health and welfare of dogs now. At a recent meeting of the Associate Parliamentary Group on Animal Welfare (APGAW) ...there was overwhelming support for provision for healthy breeding to be brought into Defra's welfare codes.
"We have long maintained that to ignore breeding in the dog welfare code is a serious oversight by Defra. In England we already have regulations that protect our farmed animals from breeding procedures that cause suffering or injury, but not for our pets. This contradictory approach makes little sense. Updating the welfare codes to include breeding would send a clear message that the Government is committed to improving the health and welfare of man's best friend."
On dangerous dogs Mr Locke renewed the BVA's call for the Government to respond to the Defra consultation, which found 77% in favour of scrapping breed-specific legislation: "Despite this overwhelming call from the public, the Government has kept its powder dry, repeatedly promising to announce its response soon.
"Secretary of State I would like to assure you that the BVA is prepared to work with all of the other organisations with an interest in dog welfare and public safety to find an effective solution. We all want to see people protected on private property; legislation that targets irresponsible owners and not just the way a dog looks; and tools that allow the police and other enforcement agencies to act swiftly to protect the public.
"And, crucially, we all want to work with you to achieve these aims."
The survey was carried out by the Institute for Employment Studies (IES), which sent it to 5,572 veterinary surgeons who graduated from a vet school in the EU (excluding the UK) and who are registered as veterinary surgeons in this country, as well as around 100 non-UK EU-trained veterinary nurses.
The survey asked a range of questions about how these individuals felt that the vote to leave the EU had affected them, how they felt about their future working in the UK veterinary sector and how they felt the College had dealt with the issue of Brexit.
3,078 people (including 19 veterinary nurses) responded to the survey – a response rate of 55.3%. The average age of the respondents was 36. 60% were female and 87% were working full-time.
The largest group of respondents (22%) qualified in Spain. 14% qualified in Italy, 10% in Poland, 9% in Romania, 7% in Portugal, 6% in Germany and 6% in the Republic of Ireland.
The remaining 26% qualified in 18 different countries, each of which accounted for fewer than 5% of EU registrants. Although these figures relate to country of qualification and not the nationality of the individuals, in 91% of cases these were the same.
The majority of respondents (78%) worked in clinical practice. Of the 603 who did not work in clinical practice, 38% worked for the Food Standards Agency, 21% worked for the Animal and Plant Health Agency and 18% worked in higher education.
The main findings of the survey were:
RCVS President Chris Tufnell said: "This survey makes the strongest possible case that the Government must act fast to reassure our EU colleagues in practices, universities and industry that they are welcome to stay in the UK.
"EU vets and vet nurses make a massive contribution to the UK veterinary sector and the health and welfare of animals and humans.
"Beyond this commitment we will also be lobbying the Government that, after we leave the EU, suitably qualified vets from overseas are prioritised for UK work visas or equivalent, particularly if they are working in public health and the meat industry.
"I have written to Michael Gove, the new Secretary of State for the Environment, Food & Rural Affairs, outlining our position and our Brexit Principles and have invited him to visit the RCVS at Belgravia House to discuss these further. I hope that he accepts our offer so that we can have some constructive talks on these matters.
"On a personal note, I am very sorry to see that a significant proportion of respondents had experienced prejudice at work. This is simply not acceptable and we, as a regulator, have been conscious that ‘anti-foreigner’ rhetoric in the country at large could have an effect on hard-working and talented members of our profession, which is why we raised the matter in our letter to the Prime Minister last year."
The findings of interviews with a sample of non-UK EU-graduated veterinary surgeons working in the UK will be published over the summer. Meanwhile, over the next two years, IES will also be carrying out two further pieces of research that will track the opinions and intentions of non-UK EU-graduated veterinary surgeons and veterinary nurses over time as Brexit policies are formed and the future status of non-UK nationals made clearer.
To read the IES report and the College’s three Brexit Principles in full, visit www.rcvs.org.uk/brexit
Chris, who is moving from Willows, will develop both the medical cardiology service and deliver a new interventional cardiology service to complement the existing surgical offering at Paragon, which is investing around £145,000 in ultrasound equipment and operating facilities to support the service.
Chris said: “I’ve had a great time at Willows and couldn’t think of a better place than Paragon to continue my passion for all things cardiology.
“It’s an exciting time to be joining Paragon, which is growing phenomenally to service the region whilst it cements itself as one of the leading referral centres in the north of England.
“The investment and expansion which is taking place at Paragon will allow us to develop another globally-recognised cardiology centre within Linnaeus.”
For more information, visit: www.paragonreferrals.co.uk
The RCVS has removed 563 veterinary surgeons from the Register from 1 June for non-payment of retention fees.
A list of those who remained off the Register as of 31 July 2012 is available here: www.rcvs.org.uk/removals2012.
The College says it is publicising the list to help make sure that those who have been removed, and their employers, are aware; it includes only those not restored prior to 31 July.
Christine Fraser, RCVS Head of Registration said: “If you know anyone who appears on this list and who is still working in the UK, you may wish to advise them they need to contact the RCVS as a matter of urgency to restore their name to the Register."
The RCVS is asking veterinary surgeons who have not yet confirmed their registration details, which is now part of the annual renewal process, to please make sure this is done by 30 September. A form was enclosed with the annual fee-reminder, or this can be done online at www.rcvs.org.uk/registration.
Information about how veterinary surgeons removed after non-payment can restore themselves to the Register is available at www.rcvs.org.uk/registration, or by contacting the RCVS Registration Department (membership@rcvs.org.uk or 0207 202 0707).
At a hearing in April Dr Johnston had admitted all the charges against him, which related fraudulent claims for the treatment of animals, two of which were fictitious, where he arranged for the insurance claims to be diverted and paid into a personal bank account.
Dr Johnston had admitted all the charges against him as well as admitting that his conduct was dishonest and amounted to serious professional misconduct.
Committee Chair Paul Morris said: “The Committee has no hesitation in concluding that the respondent’s dishonest conduct will have severely undermined the confidence of the public in the veterinary profession and, further, that his conduct fell far short of the standards and conduct properly to be expected of a member of the veterinary profession.
"The Committee is satisfied that this conduct by the respondent brought the profession into disrepute.”
The proceedings were then adjourned to allow a psychiatric report and other mitigation to be prepared.
At its resumed hearing on earlier this month, the Committee considered what sanction to impose.
The Committee found that aggravating features of his misconduct were that it was premeditated, carefully planned and sophisticated in that it involved the creation of numerous and extensive false clinical records to support his fraudulent claims.
It also considered the fact that he implicated an innocent professional colleague who worked alongside him at the practice, that he abused the trust placed in him by clients, that the dishonest conduct was repeated and that it involved significant financial gain in excess of £13,200 to be further aggravating features of his conduct
In terms of mitigation, the Committee accepted that he had made early admissions regarding his conduct to his employer and the College and accepted responsibility.
The Committee also heard that he had made attempts at remediation involving repayments of some of the sums lost by the practice and insurers.
It also considered positive testimonials from family and professional colleagues and the fact that Dr Johnston had taken significant steps to deal with the gambling addiction that was at the root cause of his misconduct.
Having considered all the evidence, the Committee decided to postpone its decision on sanction for a period of 2 years on the condition that Dr Johnston agree to undertakings including refraining from any form of gambling, subjecting himself to a close regime of support and supervision, and repaying some of the sums he had defrauded.
Paul added: “In reaching this conclusion the Committee wishes to make it clear that it has taken an exceptional course in this case.
"Ordinarily conduct of the type covered by the charges which this respondent has accepted will merit the imposition of a sanction of removal from the Register or a period of suspension from the Register.
"In this instance the Committee has found it possible to take the course that it has because it is satisfied that the respondent was, at the time, suffering from a recognisable psychiatric compulsive addiction… and that the fraudulent attempts by the respondent to obtain funds with which to gamble would not have occurred but for this psychiatric condition.
“The Committee further considers that the undertakings offered by the respondent will serve to reduce the risk that he will relapse into gambling again, for his conduct will be closely monitored and he will accept continuing support and guidance from the organisations currently assisting him.
“The Committee is also satisfied of the requirements that neither animals nor the public will be put at risk by this proposed course of action; that the respondent has demonstrated insight into the seriousness of his misconduct and that there is currently no significant risk of repeat behaviour; that his practicing standards are not in need of improvement so long as he continues to fulfil his CPD obligations; that the undertakings offered are capable of being met, are appropriate and are measurable; that there is evidence that his underlying medical problem is being appropriately addressed, will be monitored and reported on; and that he has responded positively to the opportunities for support and counselling which have been offered to him.”
If Dr Johnston fails to comply with his undertakings the Committee will reconvene and consider the charges with the full range of sanctions at its disposal.
www.rcvs.org.uk/disciplinary
The European Board of Veterinary Specialisation (EBVS) has announced that it has approved the creation of a new European College of Veterinary Emergency and Critical Care (ECVECC).
The 10 Founding Diplomates will comprise the Organising Committee of Amanda Boag, Joris Robben and Nadja Sigrist along with Sophie Adamantos, Marcel Aumann, Andrew Brown, Dan Chan, Cristina Fragio, Isabelle Goy-Thollot and Francoise Roux.
Amanda Boag, Chair of the Organising Committee said: "This is the final milestone for achieving recognition for Emergency and Critical Care as a defined speciality within Europe.
"Over the last 10 years, ECC has grown within Europe and especially the UK. Academic institutions, notably the RVC, have supported and developed ECC through their student and post graduate education.
"Commercial companies such as Vets Now have also grown and have strong internal training programmes such as the Cutting Edge.
"There are multiple opportunities for those working in practice to obtain further skills in this area with the RCVS certificate and the BSAVA/Vets Now ECC certificate and it is fantastic that we will now be able to offer European Diploma training programmes in the UK.
"Alongside this, opportunities for our nursing colleagues are growing including a large number of nurses registered for the City and Guilds Nursing Certificate in ECC delivered by Vets Now.
"Creating a European College of Veterinary Emergency and Critical Care is the last piece of the jigsaw puzzle and the Organising Committee are delighted that all the hard work of those who have been involved with the development of ECC in Europe has paid off."
The College will be formally launched at the EVECCS Congress in Prague (www.eveccs2014.org) in June.
For every 'Proud to support Dogs for Good' profile picture changed and tagged with @PetMagicMoments and #dogsaregood, Elanco will donate £1 to the charity that trains dogs to give life-changing assistance to people with disabilities.
The company is hoping to raise up to £5,000 for its long-term charity partner through the Pet Magic Moments - https://www.facebook.com/PetMagicMoments/ - Facebook picture initiative, with an overall aim of raising in excess of £15,000 in total for Dogs for Good to support the training of three assistance dogs.
Elanco says it will raise additional money through fundraising activities and employees will also be encouraged to carry out voluntary work to support Dogs for Good in the three days a year they are given to volunteer for worthwhile charities.
Matthew Rowe, marketing manager at Elanco Animal Health, said: "Our Dogs for Good Facebook picture initiative will help highlight the profile of this wonderful and inspiring charity, while raising funds to support the training of an assistance dog."
Dogs for Good (the new name for Dogs for the Disabled) is an innovative charity, exploring ways dogs can help people overcome specific challenges and enrich and improve lives and communities.
Its assistance dogs support adults and children with a range of disabilities and also children with autism. It trains activity and therapy dogs to work with specialist handlers in communities and schools and its Family Dog team also gives specialist advice and support to help people get the most out of their relationship with their pet dog.
For further information about the charity, visit www.dogsforgood.org or call on 01295 252600.